6 completed, 4 terminated. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 6, Terminated 4 |
Follow ataluren: new trials by email Literature Review of ataluren trials Research Report on ataluren
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy Ataluren, PLACEBO - Muscular Dystrophy, Duchenne, Muscular Dystrophies | Phase 3 | Completed | PTC Therapeutics | 360 | 2017-07-06 | 2026-03-10 |
| Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis Ataluren - Cystic Fibrosis | Phase 3 | Terminated | PTC Therapeutics | 246 | 2015-08-31 | 2020-04-27 |
| Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) Ataluren (PTC124®), Placebo - Cystic Fibrosis | Phase 3 | Completed | PTC Therapeutics | 279 | 2014-08-01 | 2020-05-14 |
| Study of Ataluren (PTC124) in Cystic Fibrosis Ataluren - Cystic Fibrosis | Phase 3 | Terminated | PTC Therapeutics | 61 | 2014-05-23 | 2020-03-25 |
| An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy Ataluren - Muscular Dystrophy, Duchenne, Muscular Dystrophies | Phase 3 | Terminated | PTC Therapeutics | 219 | 2014-03-20 | 2020-08-11 |
| Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Ataluren, Placebo - Muscular Dystrophy, Duchenne, Muscular Dystrophies | Phase 3 | Completed | PTC Therapeutics | 230 | 2013-03-26 | 2020-08-04 |
| Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada Ataluren - Duchenne Muscular Dystrophy, Becker Muscular Dystrophy | Phase 3 | Completed | PTC Therapeutics | 94 | 2012-05-20 | 2020-11-25 |
| Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) Ataluren - Duchenne Muscular Dystrophy | Phase 3 | Terminated | PTC Therapeutics | 265 | 2010-11-22 | 2026-10-08 |
| Extension Study of Ataluren (PTC124) in Cystic Fibrosis Ataluren - Cystic Fibrosis | Phase 3 | Completed | PTC Therapeutics | 191 | 2010-08-12 | 2020-10-19 |
| Study of Ataluren (PTC124™) in Cystic Fibrosis Ataluren, Placebo - Cystic Fibrosis | Phase 3 | Completed | PTC Therapeutics | 238 | 2009-09-08 | 2020-05-14 |
Cystic Fibrosis (5) · Muscular Dystrophy, Duchenne (5) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Muscular Diseases (3) · Muscular Disorders, Atrophic (3) · Muscular Dystrophies (3) · Musculoskeletal Diseases (3) · Nervous System Diseases (3) · Neuromuscular Diseases (3)
PTC Therapeutics (10)
Canada (9) · United States (9) · Belgium (8) · France (8) · Israel (8) · Italy (8) · Spain (8) · Germany (7) · United Kingdom (7) · Australia (6) · Sweden (6) · Brazil (5) · Poland (5) · Bulgaria (4) · Netherlands (4)
Joseph McIntosh, MD (3) · Temitayo Ajayi, MD (2) · Vinay Penematsa, MD (2) · Edward O'Mara, MD (1) · Francesco Bibbiani, M.D. (1) · Robert Spiegel, M.D. (1)
PMID 36866921, PMID 17389552, PMID 17450125, PMID 24836205, PMID 28728956, PMID 30135256, PMID 31983658, PMID 32682670, PMID 32851872, PMID 34383312, PMID 34693725, PMID 34791888, PMID 41879641
2008 (1)